by SARS-CoV-2, leading to fatal multi-organ failure.
In addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog